26S proteasome chymotrypsin-like activity — Drug Target

All drugs that target 26S proteasome chymotrypsin-like activity — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Proteasome inhibitor

Marketed (1)

• Velcade · Shilpa · Proteasome inhibitor · Oncology
  Reversible inhibitor of 26S proteasome chymotrypsin-like activity preventing ubiquitinated protein degradation.